| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
| 24,118 | 5,420 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
| 24,118 | 5,420 | | | Operating Expenses | | Research Development | 25,993 | 28,192 | 25,419 | | Selling General and Administrative | 8,109 | 8,692 | 11,308 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (34,102) | (12,766) | (31,307) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,700 | 3,594 | 4,616 | | Earnings Before Interest And Taxes | (32,402) | (9,172) | (26,691) | | Interest Expense |
-
|
-
| 69 | | Income Before Tax | (32,402) | (9,172) | (26,760) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (32,402) | (9,172) | (26,760) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (32,402) | (9,172) | (26,760) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($32,402) | ($9,172) | ($26,760) |
|
1.46% Nasdaq 
0.01 (0.44%) 
Income Statement
